Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-26-000332

Chief Executive Officer disposed of 11,834 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Virnich Daniel · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-17 Other disposition : show line 1 in the form −11,834 $3.59 $42,484 1,788,150 D
Loading xslF345X06/ownership.xml…